Prescriptions Written for ‘Office Use
Only’
A pharmacy may provide prescription drugs to a physician
for office use in accordance with §54.1-3435.02
of the Drug Control Act, which states that
A permitted pharmacy may engage in wholesale
distributions of small quantities of prescription
drugs without being licensed as a wholesale
distributor when such wholesale distributions
are in compliance with federal law as follows:
such wholesale distributions of controlled
substances do not exceed five percent of
the gross annual sales of prescription drugs
by the relevant permitted pharmacy or such
wholesale distributions of Schedules II through
V controlled substances do not exceed five
percent of the total dosage units of the Schedule
II through V controlled substances dispensed
annually by the pharmacy.
Occasionally, a physician will request prescription
drugs by providing the pharmacy with a prescription
indicating “For Office Use Only” in the name field. This
does not constitute a valid prescription because it is not
issued in the name of a specific patient for a specific drug
that resulted from a bona fide practitioner-patient relationship.
Pharmacists must not dispense prescriptions
written “For Office Use Only.” To properly transfer the
requested drugs, the pharmacist must create an invoice
containing the following information: the date of transfer,
the name and address of the physician to whom the
drugs are to be transferred, the name and address of the
pharmacy from where the drugs were transferred, and
the kind and quantity of drugs transferred. The transferring
pharmacy maintains the original invoice for two
years from the date of transfer and provides a copy to
the receiving physician or pharmacy. Once received,
the physician must indicate the date of receipt on the
invoice and maintain the invoice for two years from
the date of receipt. If the requested drug is classified as
Schedule II, the physician wishing to obtain the drug
must execute a Drug Enforcement Administration (DEA)
Form 222 as the “purchaser” and provide this form to
the transferring pharmacy. The transferring pharmacy
would then complete DEA Form 222 acting as the “supplier”
in this instance. Copies of DEA Form 222 must
then be properly forwarded as required by federal law.
If maintaining a separate record of the distribution
electronically in the pharmacy’s computer, pharmacists
must ensure that the information is not transmitted to
the PMP with other dispensing records. Assigning a
“prescription” number to the transaction may result in
the distribution information being uploaded to the PMP
quoted from here
No comments:
Post a Comment